教職人員
|
林君榮
研究領域：藥物動力學及藥效學、細胞膜轉運蛋白、神經退化疾病
本職：教授 / 藥學專業學院院長 / 藥學系主任
| 最高學歷 | : | 美國密西根大學藥劑學博士 |
| 經歷 | : | Upjohn Center for Clinical Pharmacology 研究員 醫藥品查驗中心藥動審查員 臨床藥學所講師 臨床藥學所助理教授 藥學系副教授 藥學系教授 |
| 研究領域 | : | 藥物動力學及藥效學、細胞膜轉運蛋白、神經退化疾病 |
| 研究方向 | : | (1) 細胞膜轉運蛋白之功能與分子機轉以及其與臨床應用之研究 (2) 細胞膜轉運蛋白在疾病狀態下之調控 (3) 血腦屏障 (4) 藥動學與藥效學 |
| 研究題目 | : | 1. 神經退化疾病對血腦屏障穿透性之影響 2. 細胞膜轉運蛋白在疾病產生與治療之角色與其調控 |
| 老師的話 | : | 要怎麼收穫就要怎麼栽！盡心力後而順天。 |
| 研究室要求 | : | 訓練邏輯、組織以及思考等方面能力。培養負責、盡心以及盡力的態度。 |
| 研究室成員 | : | 近幾年研究生： 林俊翰 (2017年畢) 藥學所研究生期刊論文傑出獎 論文發表於 Biochemical Pharmacology 2017; 142: 216–228 李之瑀 (2019年畢) 藥學所佳作論文獎 論文分別發表於： Neuropathology and Applied Neurobiology 2019; 45:157-173 Brain Behavior and Immunity 2020; 84:59-71 賴柏軒 (2019年畢) 醫學院研究生期刊論文優等獎 論文發表於Journal of Neuroinflammation 2021; 18:35 王庭萱 (2020年畢) 論文分別發表於： Journal of Neuroinflammation 2021; 18:35 European Journal of Pharmacology 2022; 933:175256 周芳儀 (2021年畢) 論文發表於Neurobiology of Disease 2023; 177:106004 呂喬心 (2021年畢) 醫學院研究生期刊論文佳作獎 論文發表於 Molecular Neurobiology 2023; 60:369-381 張乃有 (2021年畢) 醫學院研究生期刊論文佳作獎 論文發表於 European Journal of Pharmacology 2022; 933:175256 陳靖雅 (2022年畢) 論文發表於Neurobiology of Disease 2023; 177:106004 江蕙伶 (2022年畢) (論文投稿中) 何錦瑞 (在學) 陳玟瑜 (在學) 郭姵君 (在學) |
| 招生名額 | : | 製藥科技組：博士班一名、碩士班一名 藥物生技組：碩班一名 |
Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus
(2024-04-16) Chao, Chih‐Jia ; Gardner, Iain ; CHUN-JUNG LIN ; KUN-HUEI YEH ; Lu, Wan‐Chen ; Abduljalil, Khaled ; YUNN-FANG HO
Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome
(2024-01) Ho, Shih-Yin ; Chen, I-Chun ; Tsai, Che-Wen ; Chang, Kai-Chieh ; CHUN-JUNG LIN ; Chern, Yijuang ; HORNG-HUEI LIOU
Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impact
(2023-12) Huang, Yu-Ting ; YEN-MING HUANG ; FAN-LU KUNG ; CHUN-JUNG LIN ; TUN JAO ; YUNN-FANG HO
The Critical Role of Equilibrative Nucleoside Transporter-2 in Modulating Cerebral Damage and Vascular Dysfunction in Mice with Brain Ischemia-Reperfusion
(2023-11) Chiang, Hui-Ling ; Wu, Kuo-Chen ; Chen, You-Yin ; Ho, Chin-Jui ; Wang, Han-Lin ; Fu, Yu-Hua ; Chen, Wen-Yu ; CHUN-JUNG LIN
Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease
(2023-02) Chen, Ching-Ya ; Chou, Fang-Yi ; Chang, Ya-Gin ; Ho, Chin-Jui ; Wu, Kuo-Chen ; Hsu, Chia-Lin ; Chern, Yijuang ; CHUN-JUNG LIN
(2024-04-16) Chao, Chih‐Jia ; Gardner, Iain ; CHUN-JUNG LIN ; KUN-HUEI YEH ; Lu, Wan‐Chen ; Abduljalil, Khaled ; YUNN-FANG HO
Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome
(2024-01) Ho, Shih-Yin ; Chen, I-Chun ; Tsai, Che-Wen ; Chang, Kai-Chieh ; CHUN-JUNG LIN ; Chern, Yijuang ; HORNG-HUEI LIOU
Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impact
(2023-12) Huang, Yu-Ting ; YEN-MING HUANG ; FAN-LU KUNG ; CHUN-JUNG LIN ; TUN JAO ; YUNN-FANG HO
The Critical Role of Equilibrative Nucleoside Transporter-2 in Modulating Cerebral Damage and Vascular Dysfunction in Mice with Brain Ischemia-Reperfusion
(2023-11) Chiang, Hui-Ling ; Wu, Kuo-Chen ; Chen, You-Yin ; Ho, Chin-Jui ; Wang, Han-Lin ; Fu, Yu-Hua ; Chen, Wen-Yu ; CHUN-JUNG LIN
Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease
(2023-02) Chen, Ching-Ya ; Chou, Fang-Yi ; Chang, Ya-Gin ; Ho, Chin-Jui ; Wu, Kuo-Chen ; Hsu, Chia-Lin ; Chern, Yijuang ; CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2023-08-01～) CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2022-08-01～) CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2021-08-01～) CHUN-JUNG LIN
通過改善腦能量流失來治療阿茲海默症(1/2)
(2021-01-01～) CHUN-JUNG LIN
The Investigation of the Roles of Brain Adenosine Homeostasis on the Pathogenesis and Treatment of Parkinson'S Disease
(2020-08-01～) CHUN-JUNG LIN
(2023-08-01～) CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2022-08-01～) CHUN-JUNG LIN
The Investigation of the Roles of Equilibrative Nucleoside Transporters on Pathological Response and Disease Progression of Ischemic Stroke and Ischemia-Reperfusion Injury
(2021-08-01～) CHUN-JUNG LIN
通過改善腦能量流失來治療阿茲海默症(1/2)
(2021-01-01～) CHUN-JUNG LIN
The Investigation of the Roles of Brain Adenosine Homeostasis on the Pathogenesis and Treatment of Parkinson'S Disease
(2020-08-01～) CHUN-JUNG LIN